198 related articles for article (PubMed ID: 19269787)
1. Impact of vitamin D receptor activity on experimental autoimmune prostatitis.
Motrich RD; van Etten E; Depovere J; Riera CM; Rivero VE; Mathieu C
J Autoimmun; 2009 Mar; 32(2):140-8. PubMed ID: 19269787
[TBL] [Abstract][Full Text] [Related]
2. Expression of CXCR3 on specific T cells is essential for homing to the prostate gland in an experimental model of chronic prostatitis/chronic pelvic pain syndrome.
Breser ML; Motrich RD; Sanchez LR; Mackern-Oberti JP; Rivero VE
J Immunol; 2013 Apr; 190(7):3121-33. PubMed ID: 23455510
[TBL] [Abstract][Full Text] [Related]
3. Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP).
Rivero VE; Cailleau C; Depiante-Depaoli M; Riera CM; Carnaud C
J Autoimmun; 1998 Dec; 11(6):603-10. PubMed ID: 9878082
[TBL] [Abstract][Full Text] [Related]
4. Crucial role of interferon-gamma in experimental autoimmune prostatitis.
Motrich RD; van Etten E; Baeke F; Riera CM; Mathieu C; Rivero VE
J Urol; 2010 Mar; 183(3):1213-20. PubMed ID: 20096883
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice.
Mathieu C; Van Etten E; Gysemans C; Decallonne B; Kato S; Laureys J; Depovere J; Valckx D; Verstuyf A; Bouillon R
J Bone Miner Res; 2001 Nov; 16(11):2057-65. PubMed ID: 11697802
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate receptor modulator FTY720 suppresses rat experimental autoimmune prostatitis.
Zhang ZY; Zug C; Schluesener HJ
Scand J Immunol; 2011 Jun; 73(6):546-53. PubMed ID: 21323692
[TBL] [Abstract][Full Text] [Related]
7. HDAC inhibitor MS-275 attenuates the inflammatory reaction in rat experimental autoimmune prostatitis.
Zhang ZY; Schluesener HJ
Prostate; 2012 Jan; 72(1):90-9. PubMed ID: 21538420
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous and prostatic steroid binding protein peptide-induced autoimmune prostatitis in the nonobese diabetic mouse.
Penna G; Amuchastegui S; Cossetti C; Aquilano F; Mariani R; Giarratana N; De Carli E; Fibbi B; Adorini L
J Immunol; 2007 Aug; 179(3):1559-67. PubMed ID: 17641022
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune prostatitis: state of the art.
Motrich RD; Maccioni M; Riera CM; Rivero VE
Scand J Immunol; 2007; 66(2-3):217-27. PubMed ID: 17635799
[TBL] [Abstract][Full Text] [Related]
10. D-hormone and the immune system.
Cantorna MT; Mahon BD
J Rheumatol Suppl; 2005 Sep; 76():11-20. PubMed ID: 16142846
[TBL] [Abstract][Full Text] [Related]
11. Presence of INFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients.
Motrich RD; Maccioni M; Molina R; Tissera A; Olmedo J; Riera CM; Rivero VE
Clin Immunol; 2005 Aug; 116(2):149-57. PubMed ID: 15993362
[TBL] [Abstract][Full Text] [Related]
12. Chronic Pelvic Pain Development and Prostate Inflammation in Strains of Mice With Different Susceptibility to Experimental Autoimmune Prostatitis.
Breser ML; Motrich RD; Sanchez LR; Rivero VE
Prostate; 2017 Jan; 77(1):94-104. PubMed ID: 27699823
[TBL] [Abstract][Full Text] [Related]
13. Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol.
Penna G; Amuchastegui S; Cossetti C; Aquilano F; Mariani R; Sanvito F; Doglioni C; Adorini L
J Immunol; 2006 Dec; 177(12):8504-11. PubMed ID: 17142748
[TBL] [Abstract][Full Text] [Related]
14. Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor.
Gysemans C; van Etten E; Overbergh L; Giulietti A; Eelen G; Waer M; Verstuyf A; Bouillon R; Mathieu C
Diabetes; 2008 Jan; 57(1):269-75. PubMed ID: 17959935
[TBL] [Abstract][Full Text] [Related]
15. Reduced semen quality in chronic prostatitis patients that have cellular autoimmune response to prostate antigens.
Motrich RD; Maccioni M; Molina R; Tissera A; Olmedo J; Riera CM; Rivero VE
Hum Reprod; 2005 Sep; 20(9):2567-72. PubMed ID: 15890732
[TBL] [Abstract][Full Text] [Related]
16. Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators.
Van Etten E; Decallonne B; Verlinden L; Verstuyf A; Bouillon R; Mathieu C
J Cell Biochem; 2003 Feb; 88(2):223-6. PubMed ID: 12520518
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer induction in autoimmune rats and modulation of T cell apoptosis.
Gilardoni MB; Rabinovich GA; Oviedo M; Depiante-Depaoli M
J Exp Clin Cancer Res; 1999 Dec; 18(4):493-504. PubMed ID: 10746976
[TBL] [Abstract][Full Text] [Related]
18. [Morphological and molecular biological peculiarities of the experimental autoimmune prostatitis rat model].
Zhou XH; Han L; Zhou ZH; Liu ZD; Yang JX; Lv YW; You CL
Zhonghua Nan Ke Xue; 2005 Apr; 11(4):290-5. PubMed ID: 15921263
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic consequences in semen quality of an autoimmune response against the prostate gland: from animal models to human disease.
Motrich RD; Maccioni M; Ponce AA; Gatti GA; Oberti JP; Rivero VE
J Immunol; 2006 Jul; 177(2):957-67. PubMed ID: 16818751
[TBL] [Abstract][Full Text] [Related]
20. Experimental rodent models of prostatitis: limitations and potential.
Vykhovanets EV; Resnick MI; MacLennan GT; Gupta S
Prostate Cancer Prostatic Dis; 2007; 10(1):15-29. PubMed ID: 17199136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
